- List
- By Topic
- On Map
- Search Details

"Prader-Willi syndrome"
Need help? See RSS Feeds
Choose a feed type:

"Prader-Willi syndrome" (288 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03440814 | Not yet recruiting | A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
105 | All | 8 Years and older (Child, Adult, Senior) | NCT03440814 | C601 | March 2018 | November 2018 | December 2018 | February 21, 2018 | February 21, 2018 | |||
2 | NCT02013258 | Completed | Oxytocin Trial in Prader-Willi Syndrome |
|
|
Interventional | Phase 1 |
|
Other / NIH |
|
|
24 | All | 5 Years to 11 Years (Child) | NCT02013258 | 5208-N | March 2015 | August 2015 | August 2015 | December 17, 2013 | April 5, 2018 |
|
||
3 | NCT02034071 | Completed | Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry |
|
|
13 | All | 10 Years to 22 Years (Child, Adult) | NCT02034071 | PC025 | April 2014 | May 2015 | May 2015 | January 13, 2014 | September 1, 2016 |
|
||
4 | NCT03114371 | Recruiting | Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | All | 3 Years to 12 Years (Child) | NCT03114371 | 15 7837 03 2016-003273-18 |
Oxyjeune | November 28, 2016 | December 2019 | December 2019 | April 14, 2017 | May 5, 2017 |
|
|
5 | NCT02311673 | Completed | Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
40 | All | 16 Years to 65 Years (Child, Adult) | NCT02311673 | RM-493-010 R01FD005094-01A1 |
February 2015 | November 2016 | December 2016 | December 8, 2014 | February 9, 2018 |
|
||
6 | NCT03197662 | Recruiting | Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome |
|
|
Interventional | Phase 2 |
|
Other / U.S. Fed |
|
|
50 | All | 5 Years to 17 Years (Child) | NCT03197662 | 2017-8076 FD-R-05106-01 |
April 2018 | February 2020 | August 2020 | June 23, 2017 | April 3, 2018 |
|
||
7 | NCT02205450 | Unknown † | Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell |
|
|
Observational |
|
Other |
|
|
15 | All | up to 2 Years (Child) | NCT02205450 | CPT_ENDOPED201401 | September 2014 | September 2016 | September 2016 | July 31, 2014 | July 31, 2014 |
|
|||
8 | NCT02629991 | Active, not recruiting | Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome |
|
|
Interventional | Phase 2 |
|
Other |
|
|
24 | All | 5 Years to 18 Years (Child, Adult) | NCT02629991 | 14-10-427-01 | OXT-PWS | October 2015 | December 2016 | May 2018 | December 15, 2015 | April 2, 2018 |
|
|
9 | NCT03245762 | Completed | Intranasal Oxytocin for Infants With Prader-Willi Syndrome |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
15 | All | up to 6 Months (Child) | NCT03245762 | IRB201700423 -A | August 1, 2017 | January 4, 2018 | January 4, 2018 | August 10, 2017 | April 10, 2018 |
|
||
10 | NCT03274856 | Recruiting | A Study of GLWL-01 in Patients With Prader-Willi Syndrome |
|
|
Interventional | Phase 2 |
|
Other |
|
|
34 | All | 16 Years to 65 Years (Child, Adult) | NCT03274856 | GLWL-PWS | February 20, 2018 | September 14, 2018 | September 14, 2018 | September 7, 2017 | April 5, 2018 |
|
||
11 | NCT02829684 | Recruiting | Register of Patients With Prader-Willi Syndrome |
|
|
Observational |
|
Other |
|
|
500 | All | Child, Adult, Senior | NCT02829684 | 07 315 03 | March 2009 | December 2020 | December 2020 | July 12, 2016 | January 5, 2018 |
|
|||
12 | NCT02297022 | Unknown † | Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome |
|
|
Interventional | Phase 1 |
|
Other |
|
|
6 | All | 15 Years and older (Child, Adult, Senior) | NCT02297022 | InternalFunds | DBSPW | October 2014 | October 2016 | October 2016 | November 21, 2014 | December 16, 2015 |
|
|
13 | NCT03458416 | Not yet recruiting | A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Patients With Prader-Willi Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
66 | All | 8 Years to 17 Years (Child) | NCT03458416 | INS011-17-115 | June 2018 | May 2020 | May 2020 | March 8, 2018 | April 3, 2018 | |||
14 | NCT03101826 | Recruiting | Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory |
|
|
Interventional | Not Applicable |
|
Other |
|
|
25 | All | 13 Years to 25 Years (Child, Adult) | NCT03101826 | 1609337519 | November 1, 2017 | May 2019 | May 2019 | April 5, 2017 | November 17, 2017 |
|
||
15 | NCT02804373 | Recruiting | Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
39 | All | 18 Years to 50 Years (Adult) | NCT02804373 | 13 6872 03 | PRADOTIM | June 2014 | July 2016 | July 2016 | June 17, 2016 | June 17, 2016 |
|
|
16 | NCT03081832 | Recruiting | Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants. |
|
|
Interventional | Not Applicable |
|
Other |
|
|
36 | All | 3 Years to 4 Years (Child) | NCT03081832 | 16/8407 2016-A01348-43 |
OT2SUITE | January 2017 | December 2018 | December 2018 | March 16, 2017 | May 5, 2017 |
|
|
17 | NCT02844933 | Not yet recruiting | Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
66 | All | 8 Years to 17 Years (Child) | NCT02844933 | INS011-16-085 | April 2018 | June 2019 | June 2019 | July 26, 2016 | April 3, 2018 | |||
18 | NCT02810483 | Terminated | Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks |
|
|
Interventional | Phase 3 |
|
Other |
|
|
69 | All | 12 Years to 45 Years (Child, Adult) | NCT02810483 | AOM10088 | TOPRADER | December 2012 | November 2015 | June 2016 | June 23, 2016 | April 11, 2018 |
|
|
19 | NCT00372125 | Completed | Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
46 | All | 18 Years to 50 Years (Adult) | NCT00372125 | CH1234 | April 2005 | March 2010 | March 2010 | September 6, 2006 | September 13, 2016 |
|
||
20 | NCT02204163 | Unknown † | Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
34 | All | Child, Adult, Senior | NCT02204163 | LG-HGCL007 | June 2014 | June 2017 | July 2017 | July 30, 2014 | September 14, 2015 |
|
||
21 | NCT01444898 | Completed Has Results |
Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
10 | All | 13 Years to 20 Years (Child, Adult) | NCT01444898 | CCI 11-00227 | March 2012 | May 2013 | December 2013 | October 3, 2011 | September 29, 2016 | September 29, 2016 |
|
|
22 | NCT00932932 | Completed | Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls |
|
Observational |
|
Other |
|
36 | All | 6 Months and older (Child, Adult, Senior) | NCT00932932 | 09 01-014 | February 2009 | August 2010 | July 7, 2009 | June 27, 2011 | |||||||
23 | NCT00399893 | Terminated Has Results |
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) |
|
|
Interventional | Not Applicable |
|
Other / NIH / Industry |
|
|
5 | All | 5 Years to 21 Years (Child, Adult) | NCT00399893 | Pro00005426 Protocol #00005426 |
December 2006 | April 2009 | September 2010 | November 15, 2006 | July 24, 2014 | July 24, 2014 |
|
|
24 | NCT00444964 | Unknown † | Growth Hormone Use in Adults With Prader-Willi Syndrome |
|
|
Interventional | Phase 3 |
|
Other |
|
|
10 | All | 16 Years to 60 Years (Child, Adult) | NCT00444964 | 303-C02R | April 2005 | February 2007 | March 8, 2007 | March 8, 2007 |
|
|||
25 | NCT00551343 | Unknown † | Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years to 45 Years (Adult) | NCT00551343 | H07/045 X07-0178 |
October 2007 | September 2008 | October 30, 2007 | October 30, 2007 |
|
|||
26 | NCT02179151 | Terminated | Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
108 | All | 12 Years to 65 Years (Child, Adult) | NCT02179151 | ZAF-311 | bestPWS | September 2014 | December 2015 | October 2016 | July 1, 2014 | January 26, 2017 |
|
|
27 | NCT00175305 | Terminated | Prader-Willi Syndrome and Appetite |
|
|
Interventional | Phase 3 |
|
Other |
|
|
10 | All | 10 Years to 17 Years (Child) | NCT00175305 | C04-0007 W04-0007 |
August 2004 | October 2007 | September 15, 2005 | October 31, 2007 |
|
|||
28 | NCT03149445 | Recruiting | Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
15 | All | 18 Years to 30 Years (Adult) | NCT03149445 | TM002 | 2016-003694-18 | March 30, 2017 | September 2018 | October 2018 | May 11, 2017 | April 6, 2018 |
|
|
29 | NCT01863017 | Completed | Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
52 | All | 18 Years to 64 Years (Adult) | NCT01863017 | 13155 | April 2013 | October 6, 2016 | October 6, 2016 | May 27, 2013 | December 28, 2017 |
|
||
30 | NCT01897363 | Completed | Hypoglycemia in Prader-Willi Syndrome |
|
|
Observational |
|
Other |
|
|
2 | All | 2 Months to 12 Months (Child) | NCT01897363 | 59-2013 | July 2013 | August 2014 | September 2014 | July 12, 2013 | September 25, 2014 |
|
|||
31 | NCT00603109 | Unknown † | Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome |
|
|
Interventional | Phase 3 |
|
Other / NIH |
|
|
18 | All | 18 Years to 35 Years (Adult) | NCT00603109 | 0611008841 | PWS | August 2007 | June 2008 | August 2008 | January 28, 2008 | January 4, 2011 |
|
|
32 | NCT01622751 | Completed | Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome |
|
Observational |
|
Other |
|
46 | All | 5 Years to 12 Years (Child) | NCT01622751 | 2006-09-055 | January 2007 | June 2007 | June 19, 2012 | June 19, 2012 | |||||||
33 | NCT01479322 | Completed | Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome |
|
Observational |
|
Other |
|
51 | All | 6 Years to 18 Years (Child, Adult) | NCT01479322 | 2006-11-056 | January 2007 | July 2007 | November 24, 2011 | November 24, 2011 | |||||||
34 | NCT00800852 | Completed | Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome |
|
Observational |
|
Other | All | up to 18 Years (Child, Adult) | NCT00800852 | 2008-10-040 | December 2, 2008 | December 2, 2008 | |||||||||||
35 | NCT01298180 | Completed | Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome? |
|
|
Interventional | Phase 4 |
|
Other |
|
|
111 | All | 1 Year to 5 Years (Child) | NCT01298180 | 0811601 National PHRC 2008 |
January 2009 | May 2013 | May 2013 | February 17, 2011 | May 27, 2015 |
|
||
36 | NCT00065923 | Completed | Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome |
|
|
Interventional | Not Applicable |
|
NIH |
|
10 | All | 18 Years to 66 Years (Adult, Senior) | NCT00065923 | R03HD042818 | July 2002 | December 2005 | August 5, 2003 | May 1, 2013 |
|
||||
37 | NCT02058342 | Unknown † | Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
115 | All | 8 Years to 15 Years (Child) | NCT02058342 | HSR-13-0142.54155 W81XWH-09-1-0682 |
APAH | May 2011 | June 2015 | October 2015 | February 10, 2014 | February 10, 2014 |
|
|
38 | NCT02368379 | Completed | Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
23 | All | 2 Years and older (Child, Adult, Senior) | NCT02368379 | 293113 | March 2014 | August 2016 | August 2016 | February 23, 2015 | January 29, 2018 |
|
||
39 | NCT00808548 | Unknown † | Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi Syndrome |
|
|
Observational |
|
Other |
|
|
8 | All | 6 Years to 12 Years (Child) | NCT00808548 | C08169 | December 2008 | February 2009 | December 2009 | December 16, 2008 | December 16, 2008 |
|
|||
40 | NCT02529085 | Recruiting | PWS European Blood Bank for Infants and Controls From 0 to 48 Months |
|
|
Interventional | Not Applicable |
|
Other |
|
|
500 | All | up to 18 Years (Child, Adult) | NCT02529085 | 12 359 03 | March 2013 | March 2017 | December 2017 | August 19, 2015 | May 9, 2016 |
|
||
41 | NCT01520467 | Active, not recruiting | Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
27 | All | 5 Years to 12 Years (Child) | NCT01520467 | P 100129 AOM 10093 |
ANASILPRA | April 2012 | July 2016 | October 2016 | January 30, 2012 | August 24, 2016 |
|
|
42 | NCT00705172 | Completed | Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome |
|
|
Observational |
|
Industry |
|
|
41 | All | up to 15 Years (Child) | NCT00705172 | GHLIQUID-1961 | November 2008 | November 2008 | November 2008 | June 25, 2008 | December 23, 2014 |
|
|||
43 | NCT00742664 | Completed | Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
24 | All | 6 Years to 17 Years (Child) | NCT00742664 | FPWR-CBT-001 | September 2008 | July 2011 | July 2011 | August 28, 2008 | August 8, 2011 |
|
||
44 | NCT01613495 | Completed | Ghrelin Suppression by Octreotide in Prader-Willi |
|
|
Interventional | Not Applicable |
|
Other |
|
|
2 | Male | 18 Years and older (Adult, Senior) | NCT01613495 | eIRB #1265 OCTRI # __910_____ |
August 2005 | March 2009 | November 2010 | June 7, 2012 | June 7, 2012 | |||
45 | NCT00375089 | Completed | Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity |
|
|
Observational |
|
Other / NIH |
|
|
392 | All | up to 60 Years (Child, Adult) | NCT00375089 | RDCRN 5202 U54HD061222 ARP 5202 |
September 2006 | January 2014 | January 2014 | September 12, 2006 | September 22, 2014 |
|
|||
46 | NCT02011360 | Completed | Prader-Willi Syndrome Macronutrient Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
10 | All | 5 Years to 17 Years (Child) | NCT02011360 | Pro00049226 SFR2382 |
May 2014 | May 2016 | May 2016 | December 13, 2013 | December 14, 2016 |
|
||
47 | NCT01968187 | Completed | Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
38 | All | 10 Years to 18 Years (Child, Adult) | NCT01968187 | 000114 | January 2014 | July 2014 | July 2014 | October 23, 2013 | July 28, 2015 |
|
||
48 | NCT01523288 | Completed | The Intestinal Function in People With Prader-Willi Syndrome |
|
Observational |
|
Other |
|
|
21 | All | 18 Years and older (Adult, Senior) | NCT01523288 | PWS-1051 | February 2011 | January 2012 | January 2012 | February 1, 2012 | February 1, 2012 |
|
||||
49 | NCT01542242 | Terminated | Liraglutide Use in Prader-Willi Syndrome |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
1 | Male | 19 Years and older (Adult, Senior) | NCT01542242 | PWS.VGH.UBC | February 2012 | March 2013 | March 2013 | March 2, 2012 | December 9, 2015 |
|
||
50 | NCT01818921 | Completed | An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
17 | All | 16 Years to 65 Years (Child, Adult) | NCT01818921 | ZAF-211 | June 2013 | November 2013 | November 2013 | March 27, 2013 | July 18, 2016 |
|
† Study has passed its completion date and status has not been verified in more than two years.